Sign Up

    ANTX

    COM:AN2THERAPEUTICS

    AN2 Therapeutics

    • Stock

    1.36

    −2.16%

    0.12

    USD last updated 08/04 01:51:35

    Last Close

    1.24

    07/04 20:00

    Market Cap

    40.93M

    Beta: -

    Volume Today

    69.82K

    Avg: -

    OverviewMetricsFinancialsAPI
    Income StatementBalance SheetCash FlowKey MetricsRatios
    Quarterly
    Yearly

    Preview

    Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

    Subscribe NowHelp
    Dec '19
    Dec '20
    Dec '21
    Dec '22
    Dec '23
    net income
    -5.63M
    -
    -13.60M
    141.40%
    -21.54M
    58.37%
    -40.96M
    90.11%
    -64.73M
    58.05%
    depreciation and amortization
    -692K
    -
    deferred income tax
    stock based compensation
    40K
    -
    974K
    2,335%
    4.39M
    350.82%
    8.41M
    91.57%
    change in working capital
    -10K
    -
    1.22M
    12,340%
    32K
    97.39%
    3.72M
    11,518.75%
    5.83M
    56.91%
    accounts receivables
    inventory
    accounts payables
    -16K
    -
    81K
    606.25%
    417K
    414.81%
    2.50M
    498.80%
    553K
    77.85%
    other working capital
    6K
    -
    1.14M
    18,950%
    -385K
    133.68%
    1.22M
    417.14%
    5.28M
    332.51%
    other non cash items
    3.16M
    -
    6.97M
    120.80%
    53K
    99.24%
    77K
    45.28%
    -2.80M
    3,738.96%
    net cash provided by operating activities
    -2.49M
    -
    -5.36M
    115.77%
    -20.48M
    281.88%
    -33.46M
    63.36%
    -53.29M
    59.25%
    investments in property plant and equipment
    acquisitions net
    purchases of investments
    -77.27M
    -
    -93.84M
    21.43%
    -132.18M
    40.86%
    sales maturities of investments
    27.25M
    -
    72.06M
    164.46%
    88.90M
    23.36%
    other investing activites
    net cash used for investing activites
    -50.02M
    -
    -21.77M
    56.48%
    -43.28M
    98.79%
    debt repayment
    -11K
    -
    common stock issued
    8.08M
    -
    3.84M
    52.55%
    78.53M
    1,947.31%
    70.37M
    10.40%
    84.99M
    20.79%
    common stock repurchased
    -11K
    -
    dividends paid
    -1.82M
    -
    other financing activites
    48.50K
    -
    3.84K
    92.09%
    1.83M
    -
    19.52M
    965.81%
    net cash used provided by financing activities
    8.08M
    -
    3.84M
    52.55%
    78.53M
    1,947.31%
    70.36M
    10.42%
    84.99M
    20.81%
    effect of forex changes on cash
    net change in cash
    5.60M
    -
    -1.53M
    127.30%
    8.03M
    625.33%
    15.12M
    88.39%
    -11.57M
    176.52%
    cash at beginning of period
    5.60M
    -
    4.07M
    27.30%
    12.10M
    197.22%
    27.22M
    125.01%
    cash at end of period
    5.60M
    -
    4.07M
    27.30%
    12.10M
    197.22%
    27.22M
    125.01%
    15.65M
    42.51%
    operating cash flow
    -2.49M
    -
    -5.36M
    115.77%
    -20.48M
    281.88%
    -33.46M
    63.36%
    -53.29M
    59.25%
    capital expenditure
    free cash flow
    -2.49M
    -
    -5.36M
    115.77%
    -20.48M
    281.88%
    -33.46M
    63.36%
    -53.29M
    59.25%

    All numbers in USD (except ratios and percentages)